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Abstract 
To determine whether endogenous nitric oxide (NO) opens the ATP-sensitive K+ channel (KAV channel), we investigated the effect of nonendo- 
thelialderived NO on this channel in cultured smooth muscle cells of the porcine coronary artery by the patch-clamp technique. In the cells pretreated 
with endotoxin, the addition of lo-“ M L-arginine generated NO and activated the KATp channel. Activation of this channel was suppressed by 
pretreatment with 10e3 M NG-methyl-L-arginine or 10m3 M N”-nitro+arginine methyl ester, each of which is a specific antagonist of the L-arginme-NO 
pathway, and by 10” M Methylene blue, which blocks guanylate cyclase. The activation of the K ATp channel by L-arginine-NO pathway is expected 
to produce hyperpolarixation of the cell membrane and relaxation of vascular smooth muscle cells. 
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1. Introduction 
Vascular endothelial cells produce endothelium-de- 
rived relaxing factor (EDRF) and endothelium-derived 
hyperpolarizing factor (EDHF) in response to ace- 
tylcholine (ACh). Those substances act on smooth mus- 
cle cells [l]. EDRF is thought to consist of nitric oxide 
(NO) or of some NO compound(s) [2,3]. We questioned 
whether NO differs from, or is part of EDHFs. Vascular 
smooth muscle cells also synthesize NO from L-arginine 
[4]. Incubation with endotoxin induces the enzyme, NO 
synthase, which produces NO from L-arginine in smooth 
muscle cells [5]. NO is thought to produce guanosine 
3’,5’-cyclic monophosphate (cGMP) via the activation of 
soluble guanylate cyclase and to act on various ionic 
channels. The K’ channel is important in controlling 
vascular tone in vascular smooth muscle cells [6]. In 
vascular smooth muscle cells, the ATP-sensitive K’ 
channel (KATp channel) as well as the Ca2+-activated K+ 
channel (& channel) modulates the vascular tone [7]. 
Although nitroglycerine, a producer of NO, has been 
reported to activate the &, channel [8,9], no studies 
have been conducted on the relationship between en- 
dogenous NO formation and the activation of the K’ 
channels. Therefore, to determine whether NO may be 
a KATp channel opener and may have hyperpolarizing 
action, we investigated the effect of the L-arginine-NO 
pathway on the KATp channel using the patch-clamp 
technique. 
*Corresponding author. Fax: (81) (886) 33 1917. 
2. Materials and methods 
2. I. Cell preparation 
Smooth muscle cells were cultured by the method of Ross [lo]. In 
brief, we excised the large epicardial coronary arteries from either side 
of fresh porcine hearts that were obtained from a local slaughterhouse 
and after the endothelial tissue was removed, the arteries were cut into 
small pieces in normal Tyrode’s solution and explanted in culture 
dishes. The latter were fllled with medium 199 (Nissui Chemical, Hiro- 
shima, Japan) containing 10% fetal bovine serum (GIBCO Laborato- 
ries, Grand Island, NY), and stored in a CO* incubator (5 % CO2 at 
37°C). Four or five glass coverslips were placed on the bottom of each 
culture dish. Single smooth muscle cells migrated from the tissues dur- 
ing primary culture for 57 days and adhered to the coverslips. For 
these experiments we used single smooth muscle cells before confluence. 
We incubated these cells with endotoxin (1 @ml) for 6 h before the 
experiments. Smooth muscle cells were grown to about 25,000 cells/ml 
before confluence on 18 mm glass covet-slips. The culture medium was 
washed twice with normal Tyrode’s solution, followed by the addition 
of 2 ml of normal Tyrode’s solution to the dishes for measurement of 
NO. 
2.2. Solutions and chemicals 
Tyrode’s solution contained 137 mM NaCl, 2.7 mM KCl, 7.5 mM 
Na-[3-[N-morpholino] propanesulfonic acid (MOPS)] buffer @H 7.2), 
and 5.5 mM glucose. High K’ solution consisted of 140 mM KC1 (or 
K-aspartate) and 10 mM K-MOPS buffer @H 7.2). Ethyleneglycol- 
his@-aminoethyl ether)-N,N,K,N-tetra acetic acid (EGTA)-Ca*’ 
buffer was used to adjust the concentration of Ca” to less than 5 x lo-“ 
M. Normal l’yrode’s solution contained 1.4 r&I CaCl,. tArginme was 
obtained from GIBCO Laboratories (Grand Island, NY, USA). Fluo- 
rescein isothiocyanate-lipopolysaccharide from salmonella typhosa 
(Endotoxin), glibenclamide, NO-methyl+arginine (L-NMA), NW- 
nitro+arginine methyl ester (L-NAME) and Methylene blue were pur- 
chased from Sigma (St. Louis, MO, USA). Charybdotoxin (ChTX) was 
obtained from Peptide Institute Inc., Osaka, Japan. 
2.3. Electrophysiological measurements 
We measured the NO released from vascular smooth muscle cells 
with an NO monitor (Model NO-501, Inter Medical Co., Nagoya, 
Japan) using a porphyrinic-based microsensor modified by the method 
by Malinski and Taha [1 I]. This microsensor consisted of a working 
electrode and a counter electrode which was made of carbon fiber. A 
working electrode was made of Pt/Ir alloy coated with a three-layered 
membrane which consists of KCI, NO-selective resin, and normal sili- 
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cone membranes. In our study, the relationship between the current and 
NO concentration is linear from 0.5 nM to 5 gM (about 5.4 nM per 
pA). 
Membrane currents were recorded in cell-attached configurations 
with a patch-clamp amplifier (Model EPC-7, List Medical Electronics, 
Darmstadt, FRG), as described by Hamill et al. [12]. Soft glass patch 
pipettes prepared with an electrode puller (PP-83, Narishige Scientific 
Institute Laboratory, Tokyo, Japan) were coated with Sylgard before 
use. The electrical resistance of the patch pipettes was 5-7 M,Q for a 
single-channel recording. Experiments were conducted at 35-37°C. Be- 
:ause the conductance of the Kca channel exceeded that of the KAT P 
channel, 10 -7 M ChTX, which blocks the K ~  channel [13], was used 
to prevent its activity. Data were stored in a PCM recorder (Model 
PCM-501ES, Sony Co., Tokyo, Japan) with a low pass falter (3 kHz). 
An Axograph (Axon Instruments Inc., Foster City, CA) was used to 
analyze the data on single-channel currents. When there were multiple 
channels in the patch, the open probability (Po) was calculated as 'one 
minus the closed-channel fraction'. Results are expressed as 
means + S.E.M. 
2.4. Assay of cGMP 
After similar procedures with those of patch-clamp studies, the cul- 
tured smooth muscle cells were quickly frozen in liquid nitrogen, and 
the level of cGMP was determined by radioimmtmoassay with commer- 
cially available kits (Yamasa Shoyu, Chosi, Japan) as previously de- 
scrived [4]. 
3. Results 
We measured the NO released from vascular smooth 
muscle cells using a porphyrinic-based microsensor. 
After preincubation of the smooth muscle cells with en- 
dotoxin (1 /zg/ml) for 6 h, the addition of  10 -4 M 
L-arginine to the bath solution immediately generated 
NO (n = 4) (Fig. IA). 
In the control, cGMP level was 2.3 + 0.19 pmol.mg -~ 
protein (n = 4). 4 x 10 -4 M L-arginine did not increase 
significantly cGMP level in the cells without pretreat- 
ment of endotoxin (2.3 + 0.09 pmol 'mg -~ protein, 
n = 4). In the cultured vascular smooth muscle cells pre- 
treated with endotoxin, cGMP was increased to 
364.9 + 62.7 pmol- mg -1 protein (n = 4) (Fig. 1B). 
In a preliminary study, we found that KATe channel 
activity was infrequent in the smooth muscle cells of the 
porcine coronary artery when the concentration of Ca :+ 
in the pipette was 10 -7 M in cell-attached patch configu- 
rations [7]. Without endotoxin pretreatment, the KAav 
channel in the cell-attached configurations was activated 
by neither 10 -4 M L-arginine nor 10 -3 M L-arginine 
(n = 4, data not shown). Fig. 2 shows the effect of 
L-arginine on the KAav channel in cell-attached configu- 
rations after preincubating the smooth muscle cells with 
endotoxin (1 pg/ml) for 6 h. Single channel activities 
were infrequently observed in the control (trace a). Add- 
ing 10 -4 M L-arginine to the bath solution activated the 
KATp channel (traces b and b'). The open probability was 
less than 0.001 before the application of L-arginine, and 
0.208 + 0.041 (n = 5) after the application of L-arginine. 
In the cell-attached patch configuration, the KAaV chan- 
nel activated by 10 -4 M L-arglnine was blocked by the 
extracellular addition of  2 x 1 0  -5 M glibenclamide 
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Fig. 1. (A) Recording of the release of NO by smooth muscle cells 
incubated with endotoxin for 6 h. Addition of L-arginine (L-Arg) (10 -4 
M) increased the amount of NO released. (B) The levels of cGMP in 
the control (a). Effects of 4 x 10 -4 M L-ar~nine on the levels of cGMP 
without (b) and with (c) pretreatment of endotoxin for 24 h. 
(Po<0.001, n = 5) (trace c). The KAT P channel had 
a conductance of 30 pS in symmetrical 150 mM K + solu- 
tion. 
In the presence of 10 -3 M L-NMA, the addition of  10 -3 
M or 10 -2 M L-arginine to the bath solution did not 
activate the KATr channel (n = 5) (Fig. 3A). Similarly, in 
the presence of 10 -3 M L-NAME, 10 -3 M L-arginine did 
not activate the KArr channel (n = 4, data not shown). 
We also studied the effect of pretreating the cells with 
Methylene blue, an inhibitor of guanylate cyclase. In the 
presence of 10 -6 M Methylene blue, the KATe channel 
was not activated by 10 -3 M or 10 -2 M L-arginine (n = 5) 
(Fig. 3B). 
4. Discussion 
The Kc, channel and KAT P channel have been ob- 
served mainly in cell-attached and inside-out patch con- 
figurations in the cultured smooth muscle ceils of porcine 
coronary artery [7,14]. Standen et al. [15] showed that 
EDHF opens the KATP channel. Nitrovasodilators and 
exogenous cGMP activate the Kc, channel [8,9]. In this 
study, we investigated whether NO could open the KATe 
channel. We studied the effect of the endotoxin-induced 
L-arginine-NO pathway on the KAav channel current. 
When L-arginine was added to the bath solution of 
smooth muscle cells pretreated with endotoxin, the KAT P 
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channel was activated. L-NMA, L-NAME or Methylene 
blue suppressed this activation. There have been no stud- 
ies of the effects of cGMP on the KAW channel. In the 
present study, the KATp channel appeared to be activated 
by the L-arginine-NO pathway perhaps due to the intra- 
cellular production of NO and a subsequent increase in 
cGMP in the cell leading to hyperpolarization and in- 
tractable vasodilation. This autocrine system of the NO 
pathway by vascular smooth muscle cells may be a mech- 
anism for the development of refractory hypotension in 
patients with endotoxic shock. 
The NO produced is thought to activate soluble 
guanylate cyclase and generate cGMP. Our results are 
consistent with reports that induction of cGMP by inter- 
leukin 1 or endotoxin was maintained for several hours 
[16]. Beasley et al. [17] also showed that interleukin 1 
induced prolonged L-arginine-dependent increases in 
cGMP and NO production in rat vascular smooth mus- 
cle cells. 
Martin et al. [ 181 reported that the behavior of EDHF 
differs from that of endogenous NO. Unlike NO, EDHF 
is not inhibited by inhibitors of EDRF such as Meth- 
ylene blue or oxyhemoglobin. Chen et al. [19] noted that 
ACh-induced hyperpolarization is resistant to ni- 
troarginine, a potent inhibitor of NO formation. These 
studies indicate that EDHF or EDHFs include different 
substances other than NO, although endogenous NO 
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Fig. 2. Activation of the KATp channel by L-arginine (L-Arg). Single 
channel currents were recorded in cell-attached patch configurations 
(trace a) at a pipette voltage (V,> of +50 mV, i.e., patch membrane 
potential (Va of about -50 mV. The bath solution contained 140 mM 
KCl, 10 mM K-MOPS, and 2 mM Ca*‘, and the pipette solution 
contained 140 mM KCl, 10 mM K-MOPS, low7 M Ca”, and lo-’ M 
ChTX. The K, channel was activated by the extracellular addition 
of 10m4 M L-arginine (traces b and b’). The KATp channel, activated by 
L-arginine, was blocked by the extracellular addition of 2 x lo+ M 
glibenclamide (trace c). Downward recordings indicate the inward- 
directed transmembrane currents. Dashed lines show the zero current 
level in this and other Figures. 
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Fig. 3. Effects of L-NMA and Methylene blue (MB). The bath solution 
and the pipette solution were the same as in Fig. 2. The pipette voltage 
(VP> was +50 mV, i.e. patch membrane potential (Vd was about -50 
mV. (A) When lo-’ M L-NMA was added prior to the addition of 
L-arginine (L-Arg), the KAv channel was not activated by 10e3 M or 
lo-’ M L-arginine. (B) In the presence of 10T6 M Methylene blue, the 
KATp channel was not activated by the extracellular application of 10m3 
M or lo-* M L-arginine. 
opens the KATp channel, and might produce hyperpolar- 
ization of smooth muscle membrane. 
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